Page last updated: 2024-11-05

cyanoacetic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Cyanoacetic acid is an organic compound with the formula NCCH2CO2H. It is a white crystalline solid that is soluble in water. It is used in the synthesis of other chemicals, such as pharmaceuticals, pesticides, and dyes. Cyanoacetic acid is a versatile building block in organic synthesis, used to prepare various functional groups, such as carboxylic acids, amides, and esters. It is a valuable reagent for the preparation of heterocyclic compounds and pharmaceuticals. Cyanoacetic acid is also used as a catalyst in the synthesis of polymers. It is an important reagent in the preparation of pharmaceuticals and pesticides. It is also used as a catalyst in the synthesis of polymers. Cyanoacetic acid is toxic and can cause irritation to the skin, eyes, and respiratory system. The use of cyanoacetic acid requires careful handling and safety precautions. It is a versatile building block in organic synthesis due to its reactivity towards various nucleophiles and electrophiles. It is a key intermediate in the synthesis of many important molecules, including pharmaceuticals, pesticides, and agrochemicals. The study of cyanoacetic acid is driven by its importance in organic synthesis and its potential applications in various fields. Its reactivity, versatility, and potential for developing new and more efficient synthetic methods make it an interesting subject for research.'

cyanoacetic acid: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cyanoacetic acid : A monocarboxylic acid that consists of acetic acid bearing a cyano substituent. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID9740
CHEMBL ID3185860
CHEBI ID51889
MeSH IDM0050196

Synonyms (63)

Synonym
nsc-5571
372-09-8
cyanoacetic acid
usaf kf-17
acide cyanacetique
acetic acid, cyano-
monocyanoacetic acid
wln: qv1cn
nsc5571
malonic mononitrile
ai3-15026
nsc 5571
acide cyanacetique [french]
brn 0506325
malonic acid mononitrile
hsdb 272
kyselina kyanoctova [czech]
cyanessigsaeure [german]
einecs 206-743-9
inchi=1/c3h3no2/c4-2-1-3(5)6/h1h2,(h,5,6
cyanoacetic acid, 99%
cyanoacetic acid, >=99%
2-cyanoacetic acid
AKOS000119706
NCGC00249091-01
tox21_303155
NCGC00257182-01
cas-372-09-8
dtxsid0027149 ,
dtxcid707149
NCGC00259194-01
tox21_201645
STL146616
kyselina kyanoctova
cyanessigsaeure
ec 206-743-9
unii-qzt550h2y9
qzt550h2y9 ,
acetic acid, 2-cyano-
4-02-00-01888 (beilstein handbook reference)
FT-0624125
CHEBI:51889 ,
cyanoethanoic acid
cyanoacetic acid [mi]
cyanoacetic acid [hsdb]
2-cyano-acetic acid
alpha-cyanoacetic acid
alpha cyanoacetic acid
cyano acetic acid
alphacyanoacetic acid
cyano-acetic acid
cyanacetic acid
J-200091
ncch2cooh
CHEMBL3185860
mfcd00002677
F2191-0053
P20002
cyanoaceticacid
Q1146963
STR00053
EN300-19926
Z104476112
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
monocarboxylic acidAn oxoacid containing a single carboxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency54.48270.000714.592883.7951AID1259369; AID1259392
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency64.86010.003041.611522,387.1992AID1159552; AID1159553
retinoid X nuclear receptor alphaHomo sapiens (human)Potency54.94770.000817.505159.3239AID1159527
farnesoid X nuclear receptorHomo sapiens (human)Potency30.89940.375827.485161.6524AID743220
pregnane X nuclear receptorHomo sapiens (human)Potency64.12900.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency0.85250.000229.305416,493.5996AID743075
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency21.87510.023723.228263.5986AID743222
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency61.65240.057821.109761.2679AID1159526
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency54.48270.000323.4451159.6830AID743065
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (70)

TimeframeStudies, This Drug (%)All Drugs %
pre-199031 (44.29)18.7374
1990's2 (2.86)18.2507
2000's9 (12.86)29.6817
2010's26 (37.14)24.3611
2020's2 (2.86)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 64.32

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index64.32 (24.57)
Research Supply Index4.32 (2.92)
Research Growth Index5.18 (4.65)
Search Engine Demand Index105.08 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (64.32)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (2.70%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other72 (97.30%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]